San Francisco, California
London, United Kingdom
The Yale Office of Cooperative Research presents:
Thursday, May 22, 2014
34 Hillhouse Ave., New Haven
9 a.m.-4 p.m.
*Lunch and morning refreshments will be provided*
This day-long workshop is tailored to Yale innovators interested in commercializing ideas for drug discovery and biological therapeutics.
Emphasis will be on developing “fundable ideas” and taking an entrepreneurial approach to getting pharma and VCs to engage.
Confirmed panelists include:
Ken Carter: Chairman, Noble Life Sciences
Carrie Cox: CEO, Humacyte
Milind Deshpande: President and CEO, Achillion Pharmaceuticals
Ivor Elrifi: Partner, Cooley LLP
Brian Gallagher: Partner, SR One
Vikas Goyal: Senior Associate, SR One
Bill Harrington: Managing Partner, Osage University Partners
Chau Khuong: Private Equity Partner, OrbiMed Advisors
Gerald McMahon: CEO, Kolltan Pharmaceuticals
Harry H. Penner, Jr.: Executive Chairman & Cofounder, New Haven Pharmaceuticals
Tim Shannon: CEO, Arvinas, and Venture Partner at Canaan Partners
Jim Tobin: Vice President Cardiovascular and Metabolism Scientific Innovation, Johnson & Johnson
9:00-10:30 a.m.: “Entrepreneuring” : The Key for Commercialization in Biotech
There are many commercialization options: licensing vs. sponsored research vs. startup. All require a passion to network, listen to feedback and iterate to deeper mutual interests with prospective commercial partners. This process is key to shaping and refining a VALUE PROPOSITION that works for them. This panel will cover the keys to consider regardless of the chosen path, and how can you work towards success.
10:30 a.m.-12 p.m.: Think Like an Investor There are many funding options: Pharma, VC, Angel, SBIR, etc. All are thinking hard about navigating the FDA without burning the bank. Are you? Understanding how each makes decisions will help you pull together a story about products and people with a plan that is fundable.
12-1:30 p.m.: Lunch with One-On-One Breakouts (please note: one-on-one signups are now closed)
1:30-3:00 p.m.: Putting all the Pieces in Place
Protecting the Value Proposition: The how, when, what and why of Patenting.
What’s the Plan? It’s the most common thing missing from a business plan!
Playing the Part: How to be a “Good Founder”
Playing by the Rules: Managing Confidentiality and Conflicts of Interest
3:00-4:00 p.m.: Coffee and Networking
When & Where
Yale Office of Cooperative Research
Since its founding in 1982, the Yale Office of Cooperative Research (OCR) has built a significant portfolio of inventions and patents and has grown into an engine of regional economic development. Its mission is to facilitate the translation of research from Yale’s labs into products and services that benefit society. OCR is recognized as a leading force for catalyzing economic growth by identifying, counseling and nurturing early-stage technologies and guiding the transition into robust companies.